By creating stable cell lines containing this mutant and performing biological assays we may be able to understand the initial events that occur with TAZ overexpression and find a novel regulatory phenomenon that occurs in breast cancer initiation and progression. The gene discussed is WWTR1; the disease is breast carcinoma.